Aclaris Therapeutics, Inc.
ACRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001557746
No open-market purchases or sales by Aclaris Therapeutics, Inc. insiders were filed in the last 90 days; 148 institutions reported holding it in 13F filings for Q2 2026, worth $630.0M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Aclaris Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 81
- −16 vs. Q2 2024
- Shares held
- 50.9M
- +74.7K (+0.1%) vs. Q2 2024
- Total value
- $58.5M
- +$2.63M (+4.7%) vs. Q2 2024
- New holders
- 9
- 21 more added
- Sold out
- 25
- 28 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 148 | $630.0M |
| Q1 2026 | 136 | $409.4M |
| Q4 2025 | 122 | $252.1M |
| Q3 2025 | 103 | $162.8M |
| Q2 2025 | 96 | $130.4M |
| Q1 2025 | 109 | $143.8M |
| Q4 2024 | 98 | $217.0M |
| Q3 2024 | 81 | $58.5M |
| Q2 2024 | 98 | $58.1M |
| Q1 2024 | 98 | $67.5M |
| Q4 2023 | 107 | $61.4M |
| Q3 2023 | 138 | $480.0M |
| Q2 2023 | 133 | $737.2M |
| Q1 2023 | 149 | $579.3M |
| Q4 2022 | 128 | $1.04B |
| Q3 2022 | 127 | $1.00B |
| Q2 2022 | 115 | $883.3M |
| Q1 2022 | 110 | $1.02B |
| Q4 2021 | 133 | $814.9M |
| Q3 2021 | 126 | $1.02B |
| Q2 2021 | 128 | $983.4M |
| Q1 2021 | 97 | $1.14B |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Aclaris Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BML Capital Management, LLC | 14,250,000 | $16.4M | 9.64% | +1,261,866+9.7% | Added |
| Vanguard Group Inc | 4,685,498 | $5.39M | 0.00% | −2,0530.0% | Reduced |
| D. E. Shaw & Co., Inc. | 3,371,849 | $3.88M | 0.01% | +51,643+1.6% | Added |
| Millennium Management LLC | 3,005,598 | $3.46M | 0.00% | −331,252−9.9% | Reduced |
| Rock Springs Capital Management LP | 2,753,495 | $3.17M | 0.10% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 2,458,873 | $2.83M | 1.79% | +531,427+27.6% | Added |
| Acadian Asset Management LLC | 2,078,287 | $2.39M | 0.01% | +164,838+8.6% | Added |
| Trium Capital LLP | 1,912,990 | $2.20M | 1.01% | +20,940+1.1% | Added |
| BlackRock, Inc. | 1,711,797 | $1.97M | 0.00% | +1,711,797 | New |
| Renaissance Technologies LLC | 1,370,700 | $1.58M | 0.00% | +448,500+48.6% | Added |
| Two Sigma Advisers, LP | 1,301,500 | $1.50M | 0.00% | −135,400−9.4% | Reduced |
| Aldebaran Capital, LLC | 1,043,152 | $1.20M | 1.10% | +185,000+21.6% | Added |
| Deutsche Bank AG | 923,313 | $1.06M | 0.00% | 00.0% | Unchanged |
| Jacobs Levy Equity Management, Inc | 915,509 | $1.05M | 0.00% | +915,509 | New |
| Two Sigma Investments, LP | 907,916 | $1.04M | 0.00% | −205,156−18.4% | Reduced |
| Geode Capital Management, LLC | 846,446 | $973.6K | 0.00% | +72,309+9.3% | Added |
| Samsara BioCapital, LLC | 696,171 | $800.6K | 0.15% | 00.0% | Unchanged |
| Acuitas Investments, LLC | 578,139 | $664.9K | 0.30% | +114,019+24.6% | Added |
| Palo Alto Investors LP | 569,832 | $655.3K | 0.09% | 00.0% | Unchanged |
| FMR LLC | 545,972 | $627.9K | 0.00% | −143,381−20.8% | Reduced |
| Morgan Stanley | 480,773 | $552.9K | 0.00% | +294,430+158.0% | Added |
| Aisling Capital Management LP | 434,455 | $499.6K | 0.19% | 00.0% | Unchanged |
| Citadel Advisors LLC | 364,567 | $419.3K | 0.00% | −510,649−58.3% | Reduced |
| Connor, Clark & Lunn Investment Management Ltd. | 332,406 | $382.3K | 0.00% | +216,826+187.6% | Added |
| HighTower Advisors, LLC | 305,814 | $352.0K | 0.00% | −6,900−2.2% | Reduced |
| Goldman Sachs Group Inc | 301,556 | $346.8K | 0.00% | −615,064−67.1% | Reduced |
| Qube Research & Technologies Ltd | 292,845 | $336.8K | 0.00% | −647,907−68.9% | Reduced |
| Frazier Life Sciences Management, L.P. | 264,377 | $304.0K | 0.01% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 255,032 | $293.0K | 0.02% | −81,645−24.3% | Reduced |
| Bridgeway Capital Management, LLC | 199,119 | $229.0K | 0.00% | +48,419+32.1% | Added |
| State Street Corp | 188,721 | $217.0K | 0.00% | −7,900−4.0% | Reduced |
| Assenagon Asset Management S.A. | 185,777 | $213.6K | 0.00% | +185,777 | New |
| Squarepoint Ops LLC | 140,580 | $161.7K | 0.00% | +45,893+48.5% | Added |
| Price T Rowe Associates Inc | 139,400 | $161.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 127,225 | $146.3K | 0.00% | −393,244−75.6% | Reduced |
| ADAR1 Capital Management, LLC | 90,000 | $103.5K | 0.02% | +90,000 | New |
| Marquette Asset Management, LLC | 83,979 | $96.6K | 0.02% | 00.0% | Unchanged |
| Jane Street Group, LLC | 82,727 | $95.1K | 0.00% | −252,282−75.3% | Reduced |
| Dimensional Fund Advisors LP | 76,810 | $88.3K | 0.00% | +51+0.1% | Added |
| Susquehanna International Group, LLP | 62,408 | $71.8K | 0.00% | −144,192−69.8% | Reduced |
| BBR Partners, LLC | 60,000 | $69.0K | 0.01% | 00.0% | Unchanged |
| Point72 Asia (Singapore) Pte. Ltd. | 52,052 | $59.9K | 0.01% | −55,877−51.8% | Reduced |
| Mariner, LLC | 48,101 | $55.3K | 0.00% | +5,905+14.0% | Added |
| Cambridge Investment Research Advisors, Inc. | 41,873 | $48.0K | 0.00% | 00.0% | Unchanged |
| Engineers Gate Manager LP | 38,794 | $44.6K | 0.00% | −21,742−35.9% | Reduced |
| Tudor Investment Corp Et Al | 33,183 | $38.2K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 31,852 | $36.6K | 0.00% | −1,939−5.7% | Reduced |
| Shay Capital LLC | 27,000 | $31.1K | 0.01% | +27,000 | New |
| Tower Research Capital LLC (TRC) | 21,909 | $25.2K | 0.00% | +1,843+9.2% | Added |
| Barclays PLC | 20,393 | $23.5K | 0.00% | −19,852−49.3% | Reduced |
| Vontobel Holding Ltd. | 20,000 | $23.0K | 0.00% | 00.0% | Unchanged |
| Algert Global LLC | 19,770 | $22.7K | 0.00% | +7,990+67.8% | Added |
| AJOVista, LLC | 17,455 | $20.1K | 0.09% | +17,455 | New |
| Marex Group plc | 14,400 | $16.6K | 0.00% | 00.0% | Unchanged |
| Catalyst Funds Management Pty Ltd | 14,000 | $16.1K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 13,798 | $15.9K | 0.00% | +4,259+44.6% | Added |
| China Universal Asset Management Co., Ltd. | 13,722 | $15.8K | 0.00% | +5,350+63.9% | Added |
| Neuberger Berman Group LLC | 12,656 | $14.6K | 0.00% | 00.0% | Unchanged |
| Jefferies Financial Group Inc. | 11,500 | $13.2K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 10,740 | $12.4K | 0.00% | +10,740 | New |
| Bank of America Corp | 8,757 | $10.1K | 0.00% | +2,262+34.8% | Added |
| JPMorgan Chase & Co | 8,476 | $9.75K | 0.00% | −428−4.8% | Reduced |
| Cubist Systematic Strategies, LLC | 6,971 | $8.02K | 0.00% | −37,812−84.4% | Reduced |
| Wells Fargo & Company | 4,590 | $5.28K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 3,268 | $3.76K | 0.00% | −131−3.9% | Reduced |
| Russell Investments Group, Ltd. | 2,765 | $3.18K | 0.00% | −785−22.1% | Reduced |
| Mirae Asset Global Investments Co., Ltd. | 2,580 | $3.02K | 0.00% | +452+21.2% | Added |
| Citigroup Inc | 2,087 | $2.40K | 0.00% | −11,384−84.5% | Reduced |
| Advisor Group Holdings, Inc. | 1,732 | $1.99K | 0.00% | +1,732 | New |
| SRS Capital Advisors, Inc. | 1,632 | $1.88K | 0.00% | 00.0% | Unchanged |
| Halpern Financial, Inc. | 1,500 | $1.75K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 1,085 | $1.00K | 0.00% | −9,081−89.3% | Reduced |
| Capital Advisors, Ltd. LLC | 454 | $1.00K | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 500 | $575 | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 318 | $366 | 0.00% | −209−39.7% | Reduced |
| Truvestments Capital LLC | 150 | $173 | 0.00% | +150 | New |
| Farther Finance Advisors, LLC | 99 | $114 | 0.00% | 00.0% | Unchanged |
| Point72 (DIFC) Ltd | 92 | $106 | 0.00% | −18,227−99.5% | Reduced |
| Royal Bank of Canada | 58 | $0 | 0.00% | −4,189−98.6% | Reduced |
| Daiwa Securities Group Inc. | 248 | $0 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 1 | $0 | 0.00% | −267−99.6% | Reduced |
| Bain Capital Life Sciences Investors, LLC | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −386,177−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −260,706−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −177,909−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −118,459−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −117,966−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −114,806−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −82,883−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −81,005−100.0% | Sold out |
| Paloma Partners Management Co | 0 | $0 | 0.00% | −79,200−100.0% | Sold out |
| Deuterium Capital Management, LLC | 0 | $0 | 0.00% | −72,091−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −42,005−100.0% | Sold out |
| Mirae Asset Global ETFs Holdings Ltd. | 0 | $0 | 0.00% | −35,794−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −35,300−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −24,452−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −22,524−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −13,910−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −13,701−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −11,622−100.0% | Sold out |